|
Market Closed -
Other stock markets
|
After hours 21:55:17 | |||
| 0.8900 EUR | +0.23% |
|
0.8900 | 0.00% |
| 06-10 | AB Science presents new data on Masitinib |  |
| 05-18 | AB Science S.A. announced that it has received $2.989368 million in funding | CI |
| Market Cap | 67.97M 78.69M 62.63M 58.63M 110M 7.48B 112M 740M 288M 3.64B 295M 289M 12.61B | P/E Ratio 2025 * |
-
| P/E Ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 67.97M 78.69M 62.63M 58.63M 110M 7.48B 112M 740M 288M 3.64B 295M 289M 12.61B | EV / Sales 2025 |
95.4x | EV / Sales 2026 * | 56.6x |
| Free-Float |
67.54% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: AB Science
| 1 day | +0.23% | ||
| 1 week | -2.20% | ||
| Current month | -7.68% | ||
| 1 month | -7.68% | ||
| 3 months | -28.57% | ||
| 6 months | -27.05% | ||
| Current year | -42.06% |
| 1 week | 0.87 |  | 0.92 |
| 1 month | 0.87 | | 1.05 |
| Current year | 0.87 | | 1.61 |
| 1 year | 0.87 | | 1.73 |
| 3 years | 0.77 | | 4.97 |
| 5 years | 0.77 | | 16.68 |
| 10 years | 0.77 | | 21.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alain Moussy
CEO | Chief Executive Officer | - | 11/07/2001 |
Laurent Guy
DFI | Director of Finance/CFO | - | 20/11/2009 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Alain Moussy
CHM | Chairman | - | 11/07/2001 |
Patrick Moussy
BRD | Director/Board Member | - | 20/09/2011 |
| Director/Board Member | 64 | 27/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-20 | Sell | Chief Executive Officer | -573 | 0.0009% | ||
| 09/02/21 | Sell | Founder | 14,525 | 0.0315% | ||
| 02/02/21 | Sell | Founder | 76,104 | 0.1652% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -2.20% | -24.70% | -79.11% | 78.32M | |
| -1.59% | -2.63% | +14.43% | -21.15% | 67.84B | |
| -1.17% | -2.26% | +28.18% | +107.58% | 8.39B | |
| -1.15% | +4.39% | -3.11% | -11.24% | 7.92B | |
| -0.68% | -2.87% | -5.69% | +18.94% | 4.53B | |
| +1.05% | -3.62% | -27.99% | +34.21% | 3.72B | |
| +2.01% | +12.02% | -14.93% | +4.20% | 3.28B | |
| -2.39% | -1.04% | +35.14% | +30.25% | 2.64B | |
| +3.11% | +2.02% | +1.12% | -18.58% | 1.91B | |
| +1.99% | -1.80% | -20.75% | -22.78% | 1.69B | |
| Average | +0.16% | +2.50% | -1.83% | +4.23% | 10.2B | |
| Weighted average by Cap. | -1.01% | -0.65% | +10.49% | -3.87% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 1.1M 1.27M 1.01M 949K 1.78M 121M 1.81M 11.97M 4.67M 58.92M 4.78M 4.68M 204M | 1.2M 1.39M 1.11M 1.04M 1.94M 132M 1.97M 13.06M 5.09M 64.28M 5.21M 5.1M 223M |
| Net income | - | - |
| Net Debt | - | - |
Employees
36
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 0.8900 € | +0.23% | 169,645 |
| 11/06/26 | 0.8880 € | -2.42% | 206,532 |
| 10/06/26 | 0.9100 € | +1.79% | 200,138 |
| 09/06/26 | 0.8940 € | +1.59% | 186,613 |
| 08/06/26 | 0.8800 € | -3.30% | 433,362 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AB Stock
Select your edition
All financial news and data tailored to specific country editions
